Other Information
+Added: The Company expects to hold its 2023 Annual Meeting of Stockholders
+Added: (the “Annual Meeting”) on Thursday, March 16, 2023 and has fixed the closing of business on January 17, 2023 as the record
+Added: date for the Annual Meeting.
+Added: Because the date of the Annual Meeting has been changed by more than 30 days from the anniversary date of
+Added: the 2022 Annual Meeting of Stockholders, the Company is providing the due date for submission of any qualified stockholder proposal.
+Added: Pursuant to applicable Securities and Exchange Commission (“SEC”)
+Added: rules and the Company’s bylaws, the deadline for the submission of proposals to be included in the Company’s proxy materials
+Added: is the close of business on December 27, 2022, and the deadline for the submission of director nominations to be brought before the Annual
+Added: Meeting by a stockholder is the close of business on January 15, 2023.
+Added: Written notice for any such proposals, nominations or other business
+Added: must be received by the Company at its principal executive office (NeuroOne Medical Technologies Corporation, Attention:
+Added: Secretary, 7599
+Added: Anagram Dr., Eden Prairie, MN 55344) by the applicable deadline and must comply with the procedures and requirements of applicable SEC
+Added: rules and the Company’s bylaws.
NeuroOne Medical Technologies Corporation
−Removed: Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.4 on the Registrant’s Current Report on Form 8 filed on June 29, 2017).
−Removed: Certificate of Amendment to Amended and Restated Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.1 on the Registrant’s Current Report on Form 8-K filed on March 31, 2021).
+Added: Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.4 on the Registrant’s Current Report on Form 8-K filed on June 29, 2017).
+Added: Certificate of Amendment to Amended and Restated Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.1 on the Registrant’s Current Report on Form 8-K on March 31, 2021).
Bylaws of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.5 on the Registrant’s Current Report on Form 8-K filed on June 29, 2017).
−Removed: Warrant to Purchase Common Stock dated as of August 2, 2022 issued to Zimmer, Inc.
−Removed: Amendment No.
−Removed: 2 to Exclusive Development and Distribution Agreement dated as of July 1, 2022 by and between the Company and Zimmer, Inc.
−Removed: Amendment No.
−Removed: 3 to Exclusive Development and Distribution Agreement dated as of August 2, 2022 by and between the Company and Zimmer, Inc.
+Added: Capital on Demand TM Sales Agreement, dated December 21, 2022 between NeuroOne Medical Technologies Corporation and JonesTrading Institutional Services LLC (incorporated by reference to Exhibit 1.1 on the Registrant’s Annual Report on Form 10-K filed on December 22, 2022).
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
9 unchanged sentences
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
−Removed: are furnished, not filed.
+Added: * Documents are furnished not filed.
NeuroOne Medical Technologies Corporation
−Removed: to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by
−Removed: the undersigned thereunto duly authorized.
−Removed: August 11, 2022
−Removed: Medical Technologies Corporation
+Added: Pursuant to the requirements of the Securities
+Added: Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: February 13, 2023
+Added: NeuroOne Medical Technologies Corporation
+Added: /s/ David Rosa
Chief Executive Officer
(Principal Executive Officer)
+Added: /s/ Ronald McClurg
Ronald McClurg
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.